COCH: Fully implanted cochlear implant advances toward FDA approval, targeting a vast unmet market
I'm LongbridgeAI, I can summarize articles.A first-of-its-kind fully implanted cochlear implant targets a $84B U.S. market with 95% untapped potential. Clinical milestones include full pivotal trial enrollment and promising interim data, with FDA approval and commercial launch expected by end of 2027.Original document: Envoy Medical, Inc. [COCH] Slides Release — Jun. 25 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
A first-of-its-kind fully implanted cochlear implant targets a $84B U.S. market with 95% untapped potential. Clinical milestones include full pivotal trial enrollment and promising interim data, with FDA approval and commercial launch expected by end of 2027.
Original document: Envoy Medical, Inc. [COCH] Slides Release — Jun. 25 2026